Early 18 F-FDG PET/CT in COVID-19.
Laura CosmaSaadi SollakuViviana FrantellizziGiuseppe De VincentisPublished in: Journal of medical imaging and radiation oncology (2020)
We report the case of who has been hospitalized complaining about fever in the last 4 days. Laboratory data revealed lymphocytopenia and leucopenia with an elevation of C-reactive protein and positive real-time reverse transcription-polymerase chain reaction (RT-PCR). Six days before this hospitalization, when the patient was asymptomatic, 18 F-FDG PET/CT images were performed for the therapeutic control of liver metastases of colorectal cancer. Lung abnormality findings at 18 F-FDG PET/CT images, unrelated to cancer metastases, but suspicious for viral infection, may suggest the presence of COVID-19 disease in its early phase before symptoms onset. Since PET/CT is more sensitive than CT scan in detecting host's reaction, the added value of this technique could be monitoring disease progression and could be used as a biomarker of lung disease activity and therefore as an important tool for a better understanding of the factors that contribute to the progression of lung disease.
Keyphrases
- pet ct
- disease activity
- coronavirus disease
- liver metastases
- sars cov
- rheumatoid arthritis
- systemic lupus erythematosus
- deep learning
- computed tomography
- positron emission tomography
- convolutional neural network
- rheumatoid arthritis patients
- ankylosing spondylitis
- optical coherence tomography
- papillary thyroid
- juvenile idiopathic arthritis
- dual energy
- case report
- magnetic resonance imaging
- electronic health record
- contrast enhanced
- image quality
- machine learning
- magnetic resonance
- sleep quality
- respiratory syndrome coronavirus
- lymph node metastasis
- squamous cell
- physical activity
- data analysis